Mila Etropolski

2.6k total citations
60 papers, 1.6k citations indexed

About

Mila Etropolski is a scholar working on Physiology, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Mila Etropolski has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Physiology, 25 papers in Pharmacology and 24 papers in Anesthesiology and Pain Medicine. Recurrent topics in Mila Etropolski's work include Pain Mechanisms and Treatments (36 papers), Opioid Use Disorder Treatment (21 papers) and Pain Management and Opioid Use (18 papers). Mila Etropolski is often cited by papers focused on Pain Mechanisms and Treatments (36 papers), Opioid Use Disorder Treatment (21 papers) and Pain Management and Opioid Use (18 papers). Mila Etropolski collaborates with scholars based in United States, Germany and Belgium. Mila Etropolski's co-authors include Christine Rauschkolb, Akiko Okamoto, Bernd Lange, Achim Steup, Douglas Y. Shapiro, Brigitte Kuperwasser, Ilse Van Hove, Jüergen Häeussler, Robert Lange and Thomas Häufel and has published in prestigious journals such as Diabetes Care, The American Journal of Gastroenterology and Molecular Psychiatry.

In The Last Decade

Mila Etropolski

59 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mila Etropolski United States	19	932	736	571	556	329	60	1.6k
Christine Rauschkolb United States	15	875 0.9×	693 0.9×	730 1.3×	460 0.8×	396 1.2×	26	1.7k
Ilse Van Hove United States	13	410 0.4×	337 0.5×	373 0.7×	283 0.5×	171 0.5×	24	1.4k
Luis Enrique Chaparro Canada	12	407 0.4×	578 0.8×	521 0.9×	323 0.6×	601 1.8×	26	1.5k
M. Hale United States	19	612 0.7×	856 1.2×	529 0.9×	628 1.1×	351 1.1×	46	1.5k
Andrew C. Darke Canada	28	757 0.8×	791 1.1×	383 0.7×	382 0.7×	437 1.3×	56	2.1k
Gerhard Müller-Schwefe Germany	17	381 0.4×	429 0.6×	513 0.9×	210 0.4×	157 0.5×	61	1.2k
Thomas P. Enggaard Denmark	14	405 0.4×	528 0.7×	295 0.5×	110 0.2×	152 0.5×	24	999
Raymonda Romberg Netherlands	18	655 0.7×	839 1.1×	222 0.4×	537 1.0×	364 1.1×	23	1.9k
Seddon R. Savage United States	16	484 0.5×	804 1.1×	505 0.9×	713 1.3×	202 0.6×	24	1.6k
David A. Cherry Australia	22	789 0.8×	986 1.3×	242 0.4×	123 0.2×	761 2.3×	49	1.8k

Countries citing papers authored by Mila Etropolski

Since Specialization

Citations

This map shows the geographic impact of Mila Etropolski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mila Etropolski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mila Etropolski more than expected).

Fields of papers citing papers by Mila Etropolski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mila Etropolski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mila Etropolski. The network helps show where Mila Etropolski may publish in the future.

Co-authorship network of co-authors of Mila Etropolski

This figure shows the co-authorship network connecting the top 25 collaborators of Mila Etropolski. A scholar is included among the top collaborators of Mila Etropolski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mila Etropolski. Mila Etropolski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kern, David M., M. Soledad Cepeda, Ruby Castilla‐Puentes, Adam Savitz, & Mila Etropolski. (2021). Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting. Current Medical Research and Opinion. 37(8). 1377–1384. 4 indexed citations

Finkel, Julia C., Ronald Rosenburg, Jay Ariyawansa, et al.. (2019). <p>First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18</p>. Journal of Pain Research. Volume 12. 1925–1936. 14 indexed citations

Zhang, Liping, et al.. (2016). Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach. Clinical Drug Investigation. 37(3). 273–283. 2 indexed citations

Buynak, Robert, et al.. (2015). Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial. Clinical Therapeutics. 37(11). 2420–2438. 35 indexed citations

Galia, Eric, et al.. (2014). Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: Results of in vitro laboratory analyses. Journal of Opioid Management. 10(3). 149–158. 1 indexed citations

Schwartz, Sherwyn, Mila Etropolski, Douglas Y. Shapiro, et al.. (2014). A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy. Clinical Drug Investigation. 35(2). 95–108. 29 indexed citations

Biondi, David M., Jim Xiang, Mila Etropolski, & Bruce L. Moskovitz. (2014). Evaluation of Blood Pressure and Heart Rate in Patients with Hypertension Who Received Tapentadol Extended Release for Chronic Pain: A Post Hoc, Pooled Data Analysis. Clinical Drug Investigation. 34(8). 565–576. 12 indexed citations

Vinik, Aaron I., Douglas Y. Shapiro, Christine Rauschkolb, et al.. (2014). A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy. Diabetes Care. 37(8). 2302–2309. 81 indexed citations

Merchant, Sanjay, David Provenzano, Samir H. Mody, Kai Fai Ho, & Mila Etropolski. (2013). Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies. Journal of Opioid Management. 9(1). 51–61. 9 indexed citations

10.

Imanaka, Keiichiro, et al.. (2013). Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Current Medical Research and Opinion. 29(10). 1399–1409. 56 indexed citations

11.

Xu, Xu Steven, et al.. (2012). Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IR. Pharmaceutical Research. 29(9). 2555–2564. 18 indexed citations

12.

Biondi, David M., Jim Xiang, Mila Etropolski, & Bruce L. Moskovitz. (2011). A post hoc pooled data analysis to evaluate blood pressure (BP) and heart rate (HR) measurements in patients with a current or prior history of hypertension who received tapentadol ER, oxycodone CR, or placebo in chronic pain studies. Journal of Pain. 12(4). P55–P55. 2 indexed citations

13.

Cepeda, M. Soledad, Mila Etropolski, Rachel Weinstein, et al.. (2010). Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States. BMC Palliative Care. 9(1). 14–14. 16 indexed citations

14.

Schwartz, Sherwyn, Mila Etropolski, Douglas Y. Shapiro, et al.. (2010). Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion. 27(1). 151–162. 178 indexed citations

15.

Oh, Charles, Jens Rengelshausen, Mila Etropolski, et al.. (2010). A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 48(10). 678–687. 22 indexed citations

16.

Lange, Bernd, Brigitte Kuperwasser, Akiko Okamoto, et al.. (2010). Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Advances in Therapy. 27(6). 381–399. 136 indexed citations

17.

Camilleri, Michael, Margaret Rothman, Kai Fai Ho, & Mila Etropolski. (2010). Validation of a Bowel Function Diary for Assessing Opioid-Induced Constipation. The American Journal of Gastroenterology. 106(3). 497–506. 24 indexed citations

18.

Etropolski, Mila, et al.. (2009). A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity. Journal of Pain. 10(4). S51–S51. 4 indexed citations

19.

Etropolski, Mila, Douglas Y. Shapiro, Akiko Okamoto, et al.. (2009). 707 ANALYSIS OF EFFICACY AND SAFETY OF TAPENTADOL EXTENDED RELEASE (ER) FOR CHRONIC LOW BACK PAIN BASED ON PRIOR OPIOID EXPERIENCE. European Journal of Pain. 13(S1). 2 indexed citations

20.

Rauschkolb, Christine, Bernd Lange, Brigitte Kuperwasser, et al.. (2009). 336 TAPENTADOL EXTENDED RELEASE FOR THE RELIEF OF CHRONIC OSTEOARTHRITIS KNEE PAIN: RESULTS FROM THE EUROQOL-5 DIMENSION (EQ-5D) AND WESTERN ONTARIO AND MACMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC) QUESTIONNAIRES. Osteoarthritis and Cartilage. 17. S179–S179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact